JPH03181494A - Substance having action capable of suppressing increase of cholesterol in blood and drink and food using same substance - Google Patents
Substance having action capable of suppressing increase of cholesterol in blood and drink and food using same substanceInfo
- Publication number
- JPH03181494A JPH03181494A JP1317798A JP31779889A JPH03181494A JP H03181494 A JPH03181494 A JP H03181494A JP 1317798 A JP1317798 A JP 1317798A JP 31779889 A JP31779889 A JP 31779889A JP H03181494 A JPH03181494 A JP H03181494A
- Authority
- JP
- Japan
- Prior art keywords
- substance
- raw material
- food
- suppressing
- blood cholesterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 41
- 235000013305 food Nutrition 0.000 title claims abstract description 35
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims description 66
- 210000004369 blood Anatomy 0.000 title claims description 28
- 239000008280 blood Substances 0.000 title claims description 28
- 235000012000 cholesterol Nutrition 0.000 title description 8
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 46
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 238000011282 treatment Methods 0.000 claims abstract description 23
- 229920000642 polymer Polymers 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 13
- 235000000346 sugar Nutrition 0.000 claims abstract description 13
- 229920005610 lignin Polymers 0.000 claims abstract description 12
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims abstract description 8
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims abstract description 8
- 235000001046 cacaotero Nutrition 0.000 claims abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 8
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims abstract description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 21
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- -1 methoxyl group Chemical group 0.000 claims description 5
- 239000002244 precipitate Substances 0.000 claims description 5
- 102000013142 Amylases Human genes 0.000 claims description 4
- 108010065511 Amylases Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 4
- 239000004365 Protease Substances 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 235000019418 amylase Nutrition 0.000 claims description 4
- 230000001747 exhibiting effect Effects 0.000 claims description 4
- 238000004880 explosion Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000010025 steaming Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- 102000035195 Peptidases Human genes 0.000 claims 2
- 229940025131 amylases Drugs 0.000 claims 2
- 229940088598 enzyme Drugs 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract 2
- 239000002075 main ingredient Substances 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000000638 solvent extraction Methods 0.000 abstract 1
- 235000019219 chocolate Nutrition 0.000 description 20
- 235000012489 doughnuts Nutrition 0.000 description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 11
- 239000001814 pectin Substances 0.000 description 8
- 235000010987 pectin Nutrition 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- 229940110456 cocoa butter Drugs 0.000 description 6
- 235000019868 cocoa butter Nutrition 0.000 description 6
- 235000013325 dietary fiber Nutrition 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 6
- 235000013312 flour Nutrition 0.000 description 6
- 235000010445 lecithin Nutrition 0.000 description 6
- 239000000787 lecithin Substances 0.000 description 6
- 229940067606 lecithin Drugs 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 239000010903 husk Substances 0.000 description 5
- 235000013310 margarine Nutrition 0.000 description 5
- 239000003264 margarine Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920001277 pectin Polymers 0.000 description 5
- 238000004904 shortening Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 235000008939 whole milk Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000010855 food raising agent Nutrition 0.000 description 3
- 229920003175 pectinic acid Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 239000004382 Amylase Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019553 satiation Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/60—Deep-fried products, e.g. doughnuts
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野コ
本発明は、血中コレステロール上昇抑制作用を有する物
質およびそれを用いた飲食物に関し、更に詳しくは、カ
カオ豆の胚乳(ココアパウダー等を含む〉および/また
は外皮からそのまま、またはこれらに物理化学的処理、
生化学的前処理を加えたものから調製した血中コレステ
ロール上昇抑制作用を有する物質およびそれを用いた飲
食物に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a substance having an effect of suppressing an increase in blood cholesterol and a food or drink using the same. 〉 and/or directly from the outer skin, or subjected to physicochemical treatment,
This invention relates to a substance prepared from biochemically pretreated substances that has an effect of suppressing the rise in blood cholesterol, and to foods and drinks using the same.
[従来の技術]
多くの疫学的調査の結果から、血中総コレステロールが
高いとアテローム性動脈硬化症や虚血性心疾患の発現率
を高めることが明らかにされている。飽食の時代といわ
れる現代においては、激しい労働や運動はしないで、高
蛋白、高脂肪、更に食物繊維の少い偏った食事をたっぷ
りととる傾向に陥りがちである。[Prior Art] The results of many epidemiological studies have revealed that high blood total cholesterol increases the incidence of atherosclerosis and ischemic heart disease. In today's world, which is said to be the age of satiation, we tend to fall into the habit of eating plenty of unbalanced meals that are high in protein, high in fat, and low in dietary fiber, without engaging in strenuous labor or exercise.
このため、コレステロール調節の仕組みが乱れ、その結
果コレステロール血症が増加するに至っている。This disturbs the mechanism of cholesterol regulation, resulting in an increase in cholesterolemia.
コレステロールを低下させる食品素材としては、植物油
中の不飽和脂肪酸(n−6系)、魚油中の不飽和脂肪酸
(n−3系、EPAやDHA) 、魚介類に含まれるタ
ウリン、更にペクチン等の水溶性食物1a維が知られて
いる。Food materials that lower cholesterol include unsaturated fatty acids (n-6 series) in vegetable oil, unsaturated fatty acids (n-3 series, EPA and DHA) in fish oil, taurine contained in seafood, and pectin. Water-soluble dietary 1a fiber is known.
本発明のLGの主成分は一般にリグニンと呼ばれている
もので、水に溶は難い高分子タイプのフェノール性の物
質である。高分子化合物という点においてはペクチンや
アルギン酸と共通しているが、それらはLGと比較する
と吸湿性が高く水に溶かした時に粘性を持つために、食
品素材として大量に添加することが食品の安定性の面か
ら困難であった。The main component of the LG of the present invention is generally called lignin, which is a polymer type phenolic substance that is difficult to dissolve in water. They are similar to pectin and alginic acid in that they are polymeric compounds, but they have higher hygroscopicity than LG and are more viscous when dissolved in water, so it is important to add them in large quantities as food ingredients to ensure food stability. It was difficult from a sexual perspective.
すなわち、ペクチンやアルギン酸のような高分子化合物
は吸湿性が高く、水に溶かした時に粘性を持つために、
食品素材として大量に添加することは食品の安定性の面
から困難であり、また、タウリンの天然物はコストが高
く、更に不飽和脂肪酸はカロリーが高いという欠点があ
った。このため、食品の特性を損わず、しかも比較的大
量にに添加できる特に高分子系の素材の開発が待たれて
いた。In other words, polymer compounds such as pectin and alginic acid are highly hygroscopic and have viscosity when dissolved in water.
It is difficult to add large amounts of taurine as a food material in terms of food stability, and natural taurine is expensive, and unsaturated fatty acids have high calories. For this reason, there has been a long-awaited development of particularly polymeric materials that can be added in relatively large amounts without impairing the properties of foods.
[発明が解決しようとする課題]
この度、カカオ中の成分を各方面から研究した結果、リ
グニンを主成分とするフェノール性高分子画分(以下L
Gという)に属し、酸不溶性画分である硫酸加水分解残
渣
(LGI>とアルカリ抽出画分(LG2)とが血中コレ
ステロール上昇抑制作用を有することを突き止めた6
よって本発明は、カカオ豆の胚乳(ココアパウダー等を
含む)および/または外皮からそのまま、またはこれら
に物理化学的処理、生化学的処理を加えたものから調製
した血中コレステロール上昇抑制作用を有する物質およ
びそれを用いた血中コレステロール低下作用を有する飲
食物であって、食品の特性を損わずしかも比較的大量に
に添加できる物質およびそれを用いた飲食物を提供する
ことを目的とする。[Problem to be solved by the invention] As a result of researching the components in cacao from various aspects, we found that the phenolic polymer fraction (hereinafter referred to as L
It has been found that the acid-insoluble fraction sulfuric acid hydrolysis residue (LGI) and the alkali extraction fraction (LG2), which belong to the cacao Substances that have the effect of suppressing blood cholesterol elevation, prepared from endosperm (including cocoa powder, etc.) and/or rind as they are, or from those subjected to physicochemical or biochemical treatment, and blood cholesterol using the same. An object of the present invention is to provide a substance that has a cholesterol-lowering effect and can be added in a relatively large amount without impairing the characteristics of food, and to provide a food or drink using the same.
[課題を解決するための手段]
本発明によれば、木質系材料から抽出したフェノール性
高分子化合物のリグニンを主成分とする酸不溶性画分と
して得られることを特徴とする血中コレステロール上昇
抑制作用を有する物質が提供される。[Means for Solving the Problems] According to the present invention, the method for suppressing an increase in blood cholesterol is obtained as an acid-insoluble fraction containing lignin as a main component of a phenolic polymer compound extracted from a wood-based material. A substance having an effect is provided.
更に本発明によれば、フェノール性高分子化合物のリグ
ニンを主成分とする血中コレステロール上昇抑制作用を
有する物質であって、カカオ豆の胚乳(ココアパウダー
等を含む)および/または外皮をそのまま原料とし、ま
たは
これらに対して、粉砕、磨砕、加熱、蒸煮もしくは爆砕
のような物理的処理、各種溶媒(ヘキサン、アセトン、
エタノール等)による抽出のような化学的処理、または
発酵もしくは酵素(プロテアーゼ、アミラーゼ等〉処理
のような生化学的処理を加えたものを原料とし、
この原料に40〜98%の濃度の硫酸を2〜10倍の容
量で加えて加水分解し、ろ過、洗浄を行なった残渣とし
て得られ、
次の物理化学的特性を示すことを特徴とするLGI物質
が提供される:
分子量=200以上、
糖分:1%以下、
窒素量=1.5〜5.5%、
脂肪分=10%以下、
灰分:10%以下、
メトキシル基数=5〜40%。Furthermore, according to the present invention, the substance which has the effect of suppressing the rise in blood cholesterol and whose main component is lignin, a phenolic polymer compound, is made from the endosperm (including cocoa powder, etc.) and/or rind of cocoa beans as a raw material. physical treatments such as crushing, grinding, heating, steaming or explosion, various solvents (hexane, acetone,
The raw material is a raw material that has undergone chemical treatment such as extraction with ethanol, etc., or biochemical treatment such as fermentation or enzyme treatment (protease, amylase, etc.), and sulfuric acid with a concentration of 40 to 98% is added to this raw material. An LGI substance is provided which is obtained as a residue by adding 2 to 10 times the volume, hydrolyzing, filtering and washing, and is characterized by exhibiting the following physicochemical properties: molecular weight = 200 or more, sugar content. : 1% or less, nitrogen content = 1.5 to 5.5%, fat content = 10% or less, ash content: 10% or less, number of methoxyl groups = 5 to 40%.
なお、糖分、粗蛋白質、脂肪分、灰分についての数値は
一般分析によるものである。Note that the values for sugar content, crude protein, fat content, and ash content are based on general analysis.
更に本発明によれば、通常の食品の製造の際に添加する
ことにより、前記したLGI物質を有効成分として含有
することを特徴とする血中コレステロール上昇抑制作用
を有する飲食物が提供される。Further, according to the present invention, there is provided a food or drink having an effect of suppressing an increase in blood cholesterol, which is characterized by containing the above-mentioned LGI substance as an active ingredient by adding it during the production of ordinary foods.
更に本発明によれば、フェノール性高分子化合物のリグ
ニンを主成分とする血中コレステロール上昇抑制作用を
有する物質であって、カカオ豆の胚乳(ココアパウダー
等を含む)および/、または外皮をそのまま原料とし、
または
これらに対して、粉砕、磨砕、加熱、蒸煮もしくは爆砕
のような物理的処理、各種溶媒(ヘキサン、アセトン、
エタノール等)による抽出のような化学的処理、または
発酵もしくは酵素(プロテアーゼ、アミラーゼ等)処理
のような生化学的処理を加えたものを原料とし、
この原料に0.1〜2.0%の濃度の水酸化ナトリウム
または水酸化カリウムを10〜50@容量加え、室温ま
たは加熱しながら30分以上抽出を行い、抽出液を塩酸
で中和してpH7以下として沈澱を生成させ、更に遠心
分離またはろ過のような手段により取出し、蒸溜水で洗
浄を行った沈澱物として得られ、
次の物理化学的特性を示すことを特徴とするLG2物質
が提供される:
分子量=200以上、
糖分=1%以下、
窒素i:1.5〜5.5%、
脂肪分:10%以下、
灰分:10%以下、
メトキシル基数=5〜40%。Furthermore, according to the present invention, the substance which has the effect of suppressing the increase in blood cholesterol and whose main component is lignin, a phenolic polymer compound, is a substance which has the effect of suppressing the increase in blood cholesterol, and which is a substance which has the effect of suppressing the increase in blood cholesterol, and which is a substance that has the effect of suppressing the increase in blood cholesterol, and which is a substance that has the effect of suppressing the rise in blood cholesterol, and which is a substance that has the effect of suppressing the rise in blood cholesterol, and which is a substance that has the effect of suppressing the increase in blood cholesterol. As a raw material,
or physical treatments such as crushing, grinding, heating, steaming or explosion, various solvents (hexane, acetone,
The raw material is a raw material that has undergone chemical treatment such as extraction with ethanol, etc., or biochemical treatment such as fermentation or enzyme treatment (protease, amylase, etc.), and 0.1 to 2.0% of Add 10 to 50 volumes of concentrated sodium hydroxide or potassium hydroxide, perform extraction at room temperature or while heating for 30 minutes or more, neutralize the extract with hydrochloric acid to pH 7 or less to form a precipitate, and then centrifuge or The LG2 substance is obtained as a precipitate by removal by means such as filtration and washing with distilled water, and is characterized by exhibiting the following physicochemical properties: Molecular weight = 200 or more, Sugar content = 1% Below, Nitrogen i: 1.5-5.5%, fat content: 10% or less, ash content: 10% or less, methoxyl group number = 5-40%.
なお、糖分、粗蛋白質、脂肪分、灰分についての数値は
一般分析によるものである。Note that the values for sugar content, crude protein, fat content, and ash content are based on general analysis.
更に本発明によれば、通常の食品の製造の際に添加する
ことにより、前記したLG2物質を有効成分として含有
することを特徴とする血中コレステロール上昇抑制作用
を有する飲食物が提供される。Furthermore, according to the present invention, there is provided a food or drink having an effect of suppressing the rise in blood cholesterol, which is characterized by containing the above-mentioned LG2 substance as an active ingredient by adding it during the production of ordinary foods.
[作用]
本発明によるLGIおよびLG2は、共に木質系材料か
ら抽出される酸不溶性画分であり、フェノール性高分子
化合物のリグニンを主成分とする共通の特性を有するた
め、これらをLG画分と総称することができる。[Operation] LGI and LG2 according to the present invention are both acid-insoluble fractions extracted from wood-based materials, and have a common property of having lignin, a phenolic polymer compound, as a main component. can be collectively called.
コレステロールはホルモンの素材になったり、生体膜の
組成になる等、生体内で重要な働きを果たしており、そ
れ自体は無用の悪者ではない、しかし、現代の食生活に
おいてはコレステロールの余分な取り過ぎが問題になっ
ている。Cholesterol plays important roles in the body, such as being a material for hormones and forming biological membranes, and is not a useless evil in itself.However, in modern diets, we are eating too much cholesterol. has become a problem.
本発明はこれを解決すべく、コレステロールの血中濃度
を改善し得る物質をカカオ中に求めてLGを見出すこと
により完成されたものである。これらは原料が天然の食
品素材であるので添加量に制限がなく、それに加えてそ
れらの主成分は食物繊維であるリグニンと考えられるた
め、難吸湿性すなわち低カロリーであるという付加価値
を有する。In order to solve this problem, the present invention was completed by searching cacao for a substance that can improve blood cholesterol levels and discovering LG. Since these are natural food materials, there is no limit to the amount they can be added, and in addition, since their main component is considered to be lignin, which is a dietary fiber, they have the added value of being hygroscopically resistant, ie, low in calories.
本発明が開示したLGの主成分は、−iにリグニンと呼
ばれているもので、水に溶は難い高分子タイプのフェノ
ール性の物質である。The main component of LG disclosed in the present invention is -i called lignin, which is a polymer type phenolic substance that is difficult to dissolve in water.
高分子化合物という点では、ペクチンやアルギン酸と共
通するが、それらはLGと比較すると吸湿性が高く、水
に溶かした時に粘性を持つために、食品素材として大量
に添加することは、食品の安定性の面から困難である。In terms of polymer compounds, they are similar to pectin and alginic acid, but they have higher hygroscopicity than LG and have viscosity when dissolved in water, so adding them in large quantities as food ingredients is important for food stability. It is difficult from a sexual perspective.
本発明が開示したLGは原料が天然の食品素材であるた
め添加量に制限がなく、また吸湿性もないので食品科学
的に見ても食品への大量添加が容易である。Since the raw material of LG disclosed in the present invention is a natural food material, there is no restriction on the amount added, and since it is not hygroscopic, it can be easily added in large quantities to foods from a food science perspective.
また、特にカカオの外皮はチョコレート製造時に大量に
副生ずるが、その大部分が廃棄されているのが現状であ
り、カカオの外皮を原料として用いることはコスト面か
らも資源の有効利用という面からも非常に匿れたもので
あると考えられる。In addition, cacao husk in particular is a large amount of by-product during chocolate production, but the majority of it is currently discarded, and using cacao husk as a raw material is important from both a cost perspective and an effective use of resources. It is also considered to be very hidden.
[発明の効果]
本発明によれば、カカオ豆の胚乳(ココアパウダー等を
含む)および/または外皮からそのまま、またはこれら
に物理化学的処理、生化学的処理を加えたものから調製
した血中コレステロール上昇抑制作用を有する物質およ
びそれを用いた血圧低下作用を有する飲食物であって、
食品の特性を損わずしかも比較的大量にに添加できる物
質およびそれを用いた飲食物が提供される。[Effects of the Invention] According to the present invention, blood serum prepared from the endosperm (including cocoa powder, etc.) and/or outer skin of cocoa beans as is, or from those subjected to physicochemical treatment or biochemical treatment. A substance that has a cholesterol elevation suppressing effect and a food or drink that uses the same and has a blood pressure lowering effect,
To provide a substance that can be added in a relatively large amount without impairing the characteristics of foods, and food and drink using the same.
[実施例]
以下に実施例により本発明を更に詳細に説明するが、本
発明は以下の実施例にのみ限定されるものではない。[Examples] The present invention will be explained in more detail with reference to Examples below, but the present invention is not limited only to the following Examples.
施例1(LGIの調製)
ココアパウダー30gに300 IIlのクロロホルム
:メタノール(2:1)混液を加え、1時間攪拌して脱
脂ココアパウダーを得た。それに72%硫酸60111
+を加えて時々撹拌しながら2時間反応させた。更に
5000n+ 1の水を加えて4時間還流加熱を行った
。ろ過、洗浄後に乾燥させて10gのLGIを得た。Example 1 (Preparation of LGI) To 30 g of cocoa powder, 300 IIl of a chloroform:methanol (2:1) mixture was added and stirred for 1 hour to obtain defatted cocoa powder. Plus 72% sulfuric acid 60111
+ was added and the mixture was allowed to react for 2 hours with occasional stirring. Furthermore, 5000 n+1 water was added and heated under reflux for 4 hours. After filtering and washing, it was dried to obtain 10 g of LGI.
得られたLGIの物理化学的特性は前記した通りである
。The physicochemical properties of the obtained LGI are as described above.
12(LGIの調製
カカオハスク(カカオ豆の外皮)50gに500 ml
のヘキサンを加え、1時間撹拌して脱脂カカオハスクを
得た。それに30%硫酸1000Illを加えて1時間
還流加熱し、ろ過し、ろ液が中性になるまで洗浄を行っ
た後に凍結乾燥して10gのLGIを得た。12 (LGI preparation 500 ml to 50 g of cocoa husk (cocoa bean husk)
of hexane was added and stirred for 1 hour to obtain defatted cocoa husk. 1000 Ill of 30% sulfuric acid was added thereto, heated under reflux for 1 hour, filtered, washed until the filtrate became neutral, and then lyophilized to obtain 10 g of LGI.
得られたLGIの物理化学的特性は前記した通りである
。The physicochemical properties of the obtained LGI are as described above.
例3 (LG2の調制J)
ココアパウダー50gに500 Iltのエーテルを加
え、1時間攪拌し、ろ過によりエーテルを除き、脱脂コ
コアパウダーを得た。それに1%水酸化ナトリウム水溶
液を加えて80℃で1時間抽出を行った。抽出液を遠心
分離して固形分を除いた後、pH5に調製し、更に遠心
分離を行い、沈澱物を50℃のオーブンで乾燥させて1
2gのLG2を得た。Example 3 (LG2 Control J) 500 Ilt of ether was added to 50 g of cocoa powder, stirred for 1 hour, and the ether was removed by filtration to obtain defatted cocoa powder. A 1% aqueous sodium hydroxide solution was added thereto, and extraction was performed at 80°C for 1 hour. The extract was centrifuged to remove solids, adjusted to pH 5, further centrifuged, and the precipitate was dried in an oven at 50°C.
2g of LG2 was obtained.
得られたLG2の物理化学的特性は前記した通りである
。The physicochemical properties of the obtained LG2 are as described above.
方 4 物−例)
高血圧自然発症ラット<SHR,雄、15週齢、各群7
頭)を予備飼育後、スクロースをベースにした半合成飼
料で飼育した。Method 4 Materials - Example) Spontaneous hypertensive rats <SHR, male, 15 weeks old, 7 for each group
After pre-breeding, the animals were fed a sucrose-based semi-synthetic diet.
SHRはスクロースペースの飼料に切り替えると血it
コレステロールが上昇して行くラットである。採血はラ
ットの尾より10日自重20日目上行った0分析は、協
和メディックスのデタミナ−T C555を用いて酵素
法にて測定した。SHR loses blood when switching to sucrose space feed
These are rats whose cholesterol levels are rising. Blood was collected from the rat's tail on the 10th day of its own weight and on the 20th day. The analysis was performed by an enzymatic method using Kyowa Medix's Determiner TC555.
血中コレステロール測定結果を以下に示す。The blood cholesterol measurement results are shown below.
なお、コントロール群は7頭を用い、2%LGI添加群
と2%LG2添加群とは7頭を用いて、と、れらの平均
値として数値を示す。In addition, 7 animals were used for the control group, 7 animals were used for the 2% LGI addition group and the 2% LG2 addition group, and the numerical value is shown as the average value of these.
単位はmg/diである。(LGIとLG2は調製方法
を変えたものである。)
スタート 測置I 銭旦亘
コントロール群 60,6 126
.3 145゜82%LGI添加群 6
1.3 97.0 102.12
%LG21111g! 62.2 109.4
112.3以上の結果から、2%レベルのLGの添
加によってSHHの血漿総コレステロール上昇が抑制さ
れたことが証明された。The unit is mg/di. (LGI and LG2 have different preparation methods.) Start Measurement I Wataru Zendan control group 60,6 126
.. 3 145°82% LGI addition group 6
1.3 97.0 102.12
%LG21111g! 62.2 109.4
The results of 112.3 or higher demonstrated that the addition of 2% LG suppressed the increase in plasma total cholesterol in SHH.
5(への応用)
次の処方により原料を配合し、以下の手順によりLGI
添加チョコレートを製造した。5 (Application to) Blend the raw materials according to the following recipe, and use the following procedure to make LGI
Additive chocolate was produced.
カカオマス 15 %
粉@ 39 %
カカオバター 18 %
全脂粉乳 20 %
脱脂粉乳 5 %
レシチン 0.3%
香料 0.1%
LGI 3.0%
カカオバターおよびレシチンの一部と香料以外の原材料
とをミキサーにて粘度を児ながら混合した0次にこれら
を粒径40μ以下になるようにロールにかけた。それに
カカオバターとレシチンの残りと香料とを加えてコンチ
ングを行いチョコレート生地を作製した。これを調温し
た後にモールドに流し込み、固めて板チョコレートを製
造した。Cocoa mass 15% powder @ 39% Cocoa butter 18% Whole milk powder 20% Skim milk powder 5% Lecithin 0.3% Flavoring 0.1% LGI 3.0% Mixer of cocoa butter and part of lecithin with raw materials other than fragrance The mixture was mixed while reducing the viscosity at the same time as before, and then passed through a roll so that the particle size was 40 μm or less. Cocoa butter, the remainder of lecithin, and a flavoring agent were added thereto, and conching was performed to prepare chocolate dough. After controlling the temperature, this was poured into a mold and solidified to produce a chocolate bar.
例6(食物への応用)
次の処方により原料を配合し、実施例5と同様の手順に
よりLG2添加チョコレートを製造した。Example 6 (Application to food) Raw materials were blended according to the following recipe, and LG2-added chocolate was produced in the same manner as in Example 5.
カカオマス
粉糖
カカオバター
全脂粉乳
脱脂粉乳
レシチン
香料
G2
皮艷亘1
次の処方により原料を配合し、実施例5と15 %
39 %
18 %
20 %
5 %
0.3%
0.1%
3.0%
同様の手順によりペクチン添加チョコレートを製造した
。Cocoa mass Powdered sugar Cocoa butter Whole milk powder Skim milk Lecithin Flavoring G2 cutaneous milk 1 The raw materials were blended according to the following formulation, and Examples 5 and 15% 39% 18% 20% 5% 0.3% 0.1% 3. 0% Pectin-added chocolate was produced using the same procedure.
カカオマス 15 %
粉糖 39 %
カカオバター 18 %
全脂粉乳 20 %
脱脂粉乳 5 %
レシチン 0.3%
香料 0.1%
ペクチン 3.0%
え致皿ユ
次の処方により原料を配合し、実施例5と同様の手順に
よりノーマルチョコレートを製造した。Cocoa mass 15% Powdered sugar 39% Cocoa butter 18% Whole milk powder 20% Skimmed milk powder 5% Lecithin 0.3% Flavoring 0.1% Pectin 3.0% Raw materials were blended according to the following recipe. Normal chocolate was manufactured by the same procedure as in No. 5.
カカオマス 15 %
粉糖 42 %
カカオバター 18 %
全脂粉乳 20 %
脱脂粉乳 5 %
レシチン 0.5%
香料 0.1%
前記したようにして製造した4種類のチョコレートの試
食を行った。Cocoa mass 15% Powdered sugar 42% Cocoa butter 18% Whole milk powder 20% Skim milk powder 5% Lecithin 0.5% Flavor 0.1% Four types of chocolate produced as described above were sampled.
1枚100gの板チョコレートの場合、LG添加チョコ
レートおよびペクチン添加チョコレートとノーマルチョ
コレートとを比較すると、LG添加チョコレートおよび
ペクチン添加チョコレートではノーマルチョコレートよ
り約3g多い食物繊維を摂取することが可能である。し
たがって、LG添加チョコレートおよびペクチン添加チ
ョコレートでは、食物繊維の作用による血中コレステロ
ール上昇抑制効果を得ることができる。In the case of a 100g bar of chocolate, comparing LG-added chocolate, pectin-added chocolate, and normal chocolate, it is possible to ingest about 3g more dietary fiber in LG-added chocolate and pectin-added chocolate than in normal chocolate. Therefore, LG-added chocolate and pectin-added chocolate can have the effect of suppressing the increase in blood cholesterol due to the action of dietary fiber.
しかし、ペクチン添加チョコレートは、ペクチンの影響
によりチョコレートの粘度が高くなり口溶けが悪くなっ
た。それに対して本発明によるLG添加チョコレートは
、味の面でもノーマルチョコレートに劣らない良好な味
を示した。However, the pectin-added chocolate had a high viscosity due to the influence of pectin, which made it difficult to melt in the mouth. On the other hand, the LG-added chocolate according to the present invention exhibited a good taste comparable to that of normal chocolate.
例7(飲 への応用)
次の処方により原料を配合し、以下の手順によりLGI
添加リングドーナツを製造した。Example 7 (Application for drinking) The raw materials were blended according to the following recipe, and the LGI
Added ring donuts were made.
小麦粉 31.2%
砂@6.0%
ショートニング 1.0%
マーガリン 2.0%
粉乳 2.5%
卵 30 %
水 20 %
イースト 2.0%
食塩 0.4%
イーストフード 0,2%
乳化剤 0,1%
膨張剤 1.5%
香料 0.1%
LGl 3 %
小麦粉に食塩、砂糖、油脂類、イース1〜、乳製品、卵
、並びに水を加え、ミキシングして生地を作製した。こ
の時発酵を助けるイーストフードや乳化剤や膨張剤や香
料も加えた。Flour 31.2% Sand @ 6.0% Shortening 1.0% Margarine 2.0% Milk powder 2.5% Egg 30% Water 20% Yeast 2.0% Salt 0.4% Yeast food 0.2% Emulsifier 0 , 1% Expanding agent 1.5% Flavor 0.1% LGl 3% Salt, sugar, fats and oils, Ys 1~, dairy products, eggs, and water were added to the flour and mixed to prepare a dough. At this time, yeast food, emulsifiers, leavening agents, and flavoring agents were added to help fermentation.
次に生地を十分に発酵させ、分割し、リング状に成形し
た。更に最終発酵させ、フライヤーで揚げて製品とした
。The dough was then fully fermented, divided and shaped into rings. The product was then subjected to final fermentation and fried in a fryer.
8〈 への応 )
次の処方により原料を配合し、実施例7と同様の手順に
よりLG2添加リングドーナツを製造した。8 (Response to ) Raw materials were blended according to the following recipe, and LG2-added ring donuts were produced in the same manner as in Example 7.
小麦粉 31.2%
砂@i 6.0%
ショートニング 1.0%
マーガリン 2.0%
粉乳 2.5%
卵 30 %
水 20 %
イースト 2.0%
食塩 0.4%
イーストフード 0.2%
乳化剤 0.1%
膨張剤 1.5%
香料 0.1%
LG2 3 %
比10生1
次の処方により原料を配合し、実施例7と同様の手順に
よりペクチン添加リングドーナツを製造した。Flour 31.2% Sand@i 6.0% Shortening 1.0% Margarine 2.0% Milk powder 2.5% Eggs 30% Water 20% Yeast 2.0% Salt 0.4% Yeast food 0.2% Emulsifier 0.1% Expanding agent 1.5% Flavor 0.1% LG2 3% Ratio 10 Fresh 1 Raw materials were blended according to the following recipe, and pectin-added ring donuts were produced in the same manner as in Example 7.
小麦粉 31.2%
砂糖 6.0%
ショートニング 1.0%
マーガリン 2.0%
粉乳 2.5%
卵 30 %
水 20 %
イースト 2.0%
食塩 0.4%
イーストフード 0.2%
乳化剤 0.1%
膨張剤 1.5%
香料 0.1%
ペクチン 3.0%
息致皿1
次の処方により原料を配合し、実施例7と同様の手順に
よりEPA添加リングドーナツを製造した。Flour 31.2% Sugar 6.0% Shortening 1.0% Margarine 2.0% Milk powder 2.5% Eggs 30% Water 20% Yeast 2.0% Salt 0.4% Yeast food 0.2% Emulsifier 0. 1% Expanding agent 1.5% Flavor 0.1% Pectin 3.0% Breathing dish 1 Raw materials were blended according to the following recipe, and EPA-added ring donuts were produced in the same manner as in Example 7.
小麦粉 34.2%
砂糖 6.0%
ショートニング 0.5%
マーガリン 1.5%
粉乳 2.5%
卵 30 %
水 20 %
イースト 2.0%
食塩 0.4%
イーストフード 0.2%
乳化剤 0.1%
膨脹剤 1.5%
香料 0.1%
EPA 1.0%
皮敗盟互
次の処方により原料を配合し、実施例7と同様の手順に
よりノーマルリングドーナツを製造した。Flour 34.2% Sugar 6.0% Shortening 0.5% Margarine 1.5% Milk powder 2.5% Eggs 30% Water 20% Yeast 2.0% Salt 0.4% Yeast food 0.2% Emulsifier 0. 1% Leavening agent 1.5% Flavoring agent 0.1% EPA 1.0% The raw materials were blended according to the following recipe, and normal ring donuts were produced in the same manner as in Example 7.
小麦粉 34.2%
砂¥Ii 6.0%
ショートニング 1.0%
マーガリン 2.0%
粉乳 2.5%
卵 30 %水
202g
イースト 2.0%
食塩 0.4%
イーストフード 062%
乳化剤 0.1%
膨脹剤 1.5%
香料 0,1%
前記したようにして製造した5種類のリング、゛−ナツ
の試食を行った。Flour 34.2% Sand¥Ii 6.0% Shortening 1.0% Margarine 2.0% Milk powder 2.5% Egg 30% Water
202g Yeast 2.0% Salt 0.4% Yeast food 062% Emulsifier 0.1% Leavening agent 1.5% Flavoring 0.1% Five types of rings and nuts produced as described above were tasted. Ta.
2個で100 gのリングドーナツの場合、LG添加リ
ングドーナツおよびペクチン添加リングドーナツとノー
マルリングドーナツとを比較すると、LG添加リングド
ーナツおよびペクチン添加リングドーナツではノーマル
リングドーナツより約3g多い食物繊維を摂取すること
が可能である。したがって、LG添加リングドーナツお
よびペクチン添加リングドーナツでは、食物繊維の作用
による血中コレステロール上昇抑制効果を得ることがで
きる。In the case of two ring donuts weighing 100 g, comparing LG-added ring donuts, pectin-added ring donuts, and normal ring donuts, the LG-added ring donuts and pectin-added ring donuts intake about 3 g more dietary fiber than the normal ring donuts. It is possible to do so. Therefore, in the LG-added ring donut and the pectin-added ring donut, the effect of suppressing the increase in blood cholesterol due to the action of dietary fiber can be obtained.
しかし、ペクチン添加リングドーナツは、ペクチンの影
響によりリングドーナツ生地の粘度が高くなり発酵が不
十分であったり、保存時に吸湿したりする問題点が生じ
た。それに対して本発明によるLG添加リングドーナツ
は、味の面でもノーマルリングドーナツに劣らない良好
な味を示した。However, pectin-added ring donuts have problems such as increased viscosity of the ring donut dough due to the influence of pectin, insufficient fermentation, and moisture absorption during storage. On the other hand, the LG-added ring donut according to the present invention had a good taste comparable to that of the normal ring donut.
EPA添加リングドーナツはクルードなりPAを用いた
ためか魚臭が強く、リングドーナツ本来の香りが隠され
てしまい、嗜好性が極めて低かった。The EPA-added ring donut had a strong fish odor probably due to the use of crude PA, which masked the original aroma of the ring donut, resulting in extremely low palatability.
Claims (5)
物のリグニンを主成分とする酸不溶性画分として得られ
ることを特徴とする血中コレステロール上昇抑制作用を
有する物質。(1) A substance having an effect of suppressing an increase in blood cholesterol, which is obtained as an acid-insoluble fraction containing lignin as a main component of a phenolic polymer compound extracted from a wood-based material.
する血中コレステロール上昇抑制作用を有する物質であ
って、 カカオ豆の胚乳(ココアパウダー等を含む)および/ま
たは外皮をそのまま原料とし、または これらに対して、粉砕、磨砕、加熱、蒸煮 もしくは爆砕のような物理的処理、各種溶媒(ヘキサン
、アセトン、エタノール等)による抽出のような化学的
処理、または発酵もしくは酵素(プロテアーゼ、アミラ
ーゼ等)処理のような生化学的処理を加えたものを原料
とし、 この原料に40〜98%の濃度の硫酸を2〜10倍の容
量で加えて加水分解し、ろ過、洗浄を行なった残渣とし
て得られ、 次の物理化学的特性を示すことを特徴とす るLG1物質: 分子量:200以上、 糖分:1%以下、 窒素量:1.5〜5.5%、 脂肪分:10%以下、 灰分:10%以下、 メトキシル基数:5〜40%。(2) A substance that has the effect of suppressing an increase in blood cholesterol and whose main component is lignin, a phenolic polymer compound, which is made from the endosperm (including cocoa powder, etc.) and/or rind of cacao beans, or physical treatments such as crushing, grinding, heating, steaming or explosion, chemical treatments such as extraction with various solvents (hexane, acetone, ethanol, etc.), or fermentation or enzymes (proteases, amylases, etc.) The raw material is one that has been subjected to biochemical treatments such as biochemical treatment, and the raw material is hydrolyzed by adding 2 to 10 times the volume of sulfuric acid with a concentration of 40 to 98%, and obtained as a residue after filtering and washing. LG1 substance characterized by exhibiting the following physicochemical properties: Molecular weight: 200 or more, Sugar content: 1% or less, Nitrogen content: 1.5 to 5.5%, Fat content: 10% or less, Ash content: 10% or less, methoxyl group number: 5-40%.
求項2記載のLG1物質を有効成分として含有すること
を特徴とする血中コレステロール上昇抑制作用を有する
飲食物。(3) A food or drink having an effect of suppressing an increase in blood cholesterol, which contains the LG1 substance according to claim 2 as an active ingredient by adding it during the production of ordinary foods.
する血中コレステロール上昇抑制作用を有する物質であ
つて、 カカオ豆の胚乳(ココアパウダー等を含む)および/ま
たは外皮をそのまま原料とし、または これらに対して、粉砕、磨砕、加熱、蒸煮 もしくは爆砕のような物理的処理、各種溶媒(ヘキサン
、アセトン、エタノール等)による抽出のような化学的
処理、または発酵もしくは酵素(プロテアーゼ、アミラ
ーゼ等)処理のような生化学的処理を加えたものを原料
とし、 この原料に0.1〜2.0%の濃度の水酸化ナトリウム
または水酸化カリウムを10〜50倍容量加え、室温ま
たは加熱しながら30分以上抽出を行い、抽出液を塩酸
で中和してpH7以下として沈澱を生成させ、更に遠心
分離またはろ過のような手段により取出し、蒸溜水で洗
浄を行った沈澱物として得られ、 次の物理化学的特性を示すことを特徴とす るLG2物質: 分子量:200以上、 糖分:1%以下、 窒素量:1.5〜5.5%、 脂肪分:10%以下、 灰分:10%以下、 メトキシル基数:5〜40%。(4) A substance that has the effect of suppressing an increase in blood cholesterol and whose main component is lignin, a phenolic polymer compound, made from the endosperm (including cocoa powder, etc.) and/or outer skin of cacao beans, or physical treatments such as crushing, grinding, heating, steaming or explosion, chemical treatments such as extraction with various solvents (hexane, acetone, ethanol, etc.), or fermentation or enzymes (proteases, amylases, etc.) The raw material is one that has been subjected to biochemical treatments such as hydroxide treatment, and 10 to 50 times the volume of sodium hydroxide or potassium hydroxide at a concentration of 0.1 to 2.0% is added to this raw material, and the mixture is heated at room temperature or while heating. Extraction is carried out for 30 minutes or more, the extract is neutralized with hydrochloric acid to a pH of 7 or lower to form a precipitate, and the precipitate is further removed by means such as centrifugation or filtration and washed with distilled water. LG2 substance characterized by exhibiting the following physicochemical properties: Molecular weight: 200 or more, Sugar content: 1% or less, Nitrogen content: 1.5 to 5.5%, Fat content: 10% or less, Ash content: 10% or less , Methoxyl group number: 5-40%.
求項4記載のLG2物質を有効成分として含有すること
を特徴とする血中コレステロール上昇抑制作用を有する
飲食物。(5) A food or drink having an effect of suppressing an increase in blood cholesterol, which contains the LG2 substance according to claim 4 as an active ingredient by adding it during the production of ordinary foods.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1317798A JP2588615B2 (en) | 1989-12-08 | 1989-12-08 | Blood cholesterol elevation inhibitor |
US07/623,545 US5171570A (en) | 1989-12-08 | 1990-12-07 | Substance having suppressing function for diseases relating to increase in cholesterol, and foods and drinks in which it is used |
EP90123663A EP0431650A1 (en) | 1989-12-08 | 1990-12-08 | A substance having suppressing function for diseases relating to increase in cholesterol, and foods and drinks in which it is used |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1317798A JP2588615B2 (en) | 1989-12-08 | 1989-12-08 | Blood cholesterol elevation inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03181494A true JPH03181494A (en) | 1991-08-07 |
JP2588615B2 JP2588615B2 (en) | 1997-03-05 |
Family
ID=18092160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1317798A Expired - Fee Related JP2588615B2 (en) | 1989-12-08 | 1989-12-08 | Blood cholesterol elevation inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2588615B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3721735A (en) * | 1970-07-15 | 1973-03-20 | C Thiffault | Compositions for and method of lowering cholesterol levels |
JPS55141415A (en) * | 1979-04-24 | 1980-11-05 | Boosoo Yushi Kk | Substance controlling the increase in serum cholosterol, which is separated from defatted rice bran |
JPH01317799A (en) * | 1988-06-17 | 1989-12-22 | Honda Motor Co Ltd | Lamination apparatus |
JPH01317800A (en) * | 1988-06-17 | 1989-12-22 | Minolta Camera Co Ltd | Method for forming stereoscopic image |
-
1989
- 1989-12-08 JP JP1317798A patent/JP2588615B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3721735A (en) * | 1970-07-15 | 1973-03-20 | C Thiffault | Compositions for and method of lowering cholesterol levels |
JPS55141415A (en) * | 1979-04-24 | 1980-11-05 | Boosoo Yushi Kk | Substance controlling the increase in serum cholosterol, which is separated from defatted rice bran |
JPH01317799A (en) * | 1988-06-17 | 1989-12-22 | Honda Motor Co Ltd | Lamination apparatus |
JPH01317800A (en) * | 1988-06-17 | 1989-12-22 | Minolta Camera Co Ltd | Method for forming stereoscopic image |
Also Published As
Publication number | Publication date |
---|---|
JP2588615B2 (en) | 1997-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190208796A1 (en) | Methods of Separating Fat From Non-Soy Plant Materials and Compositions Produced Therefrom | |
US7629010B2 (en) | Process of extracting citrus fiber from citrus vesicles | |
US20070207254A1 (en) | Methods of separating fat from soy materials and compositions produced therefrom | |
CN109068680A (en) | Composition derived from functional mung bean | |
US5171570A (en) | Substance having suppressing function for diseases relating to increase in cholesterol, and foods and drinks in which it is used | |
KR101963129B1 (en) | Method for manufacturing bread using stevia extract and bread manufactured by the same | |
DE102009039363A1 (en) | Providing food intermediate- or food end-products, comprises preparing e.g. linseed and crushed linseed, separating together with e.g. natural products, preferably psyllium husks and hydrocolloids into fractions by e.g. crushing | |
JP4294107B2 (en) | Feed additives | |
JPH05140583A (en) | Production of flavored oil having fragrant flavor | |
US3780183A (en) | Plant protein product and process | |
JPH11308978A (en) | Hypercholesterolemia preventive beverage and food | |
KR101970777B1 (en) | Method for manufacturing cream bread using yogurt and cream bread using yogurt manufactured by the same | |
JPH03181494A (en) | Substance having action capable of suppressing increase of cholesterol in blood and drink and food using same substance | |
KR101968926B1 (en) | Method for refining deer horn extract, the refined deer horn extract and a composition comprising the refined deer horn extract | |
JP2588617B2 (en) | Cholesterol gallstone formation inhibitor | |
JP2588616B2 (en) | Substance having a blood pressure elevation inhibitory action and food and drink using the same | |
KR920003054B1 (en) | Process making food inclusive of dietary fiber | |
KR870000023B1 (en) | Method for making protein extract from lupinseed | |
US20230193153A1 (en) | Process for making oil-free compositions comprising phospholipds | |
EP3955753A1 (en) | Compositions and uses thereof | |
Luo | The production of food-grade protein isolates from yellow mustard seed by solvent extraction and membrane processng techniques | |
CN113303372A (en) | Rice oil with rice fragrance series flavor and preparation method thereof | |
JP2007210943A (en) | Composition for improving lipid metabolism | |
JP2006238783A (en) | Functional rice cracker | |
JPH069483B2 (en) | Low cholesterol egg yolk manufacturing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081205 Year of fee payment: 12 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081205 Year of fee payment: 12 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081205 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091205 Year of fee payment: 13 |
|
LAPS | Cancellation because of no payment of annual fees |